How does a biparatopic CXCR2 nanobody inhibit with high potency and efficacy?
Integral Molecular News
Epitope Mapping – Novartis Case Study
- October 22, 2016
Upcoming Events
SITC
11/1 – 11/5 | San Diego, CA
Vaccines R&D
11/6 – 11/8 | Baltimore, MD
BIO- Europe
11/6 – 11/8 | Munich, Germany
